Syros Pharmaceuticals (SYRS) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St set to open lower as oil, bond yields tick up
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
Syros Pharmaceuticals (SYRS) PT Lowered to $26 at Oppenheimer
August 7, 2018 10:34 AM EDTOppenheimer lowered its price target on Syros Pharmaceuticals (NASDAQ: SYRS) to $26.00 (from $28.00) while maintaining a Outperform rating.
... More